Revised June 2012
NIDA supports state-of-the-art genetic/genomic and epigenetic research in the basic, clinical and population sciences of drug addiction. Elucidation of genetic factors, their interactions with behavioral, social, and physical environments, and their relationship to specific phenotypes and associated outcomes including HIV/AIDS, are critical to determining addiction vulnerabilities, and will ultimately help facilitate diagnosis, treatment, and prevention. Read more...
Funding for Genetics Research:
- Genetics Funding Opportunity Announcements
- Human Genetics Grant Application Guidelines
- NIH and NIDA Data Sharing Policies
- NIH Guide Notice of NIDA’s Priorities for Human Genetics Research
- Use NIH RePORTER to see NIDA Genetics Portfolio
Scientific Meetings Calendar:
NIDA Resources and Contacts:
- NIDA Genetics Workgroup
- NIDA Genetics Study Center (biorepository)
- Genetics and Molecular Neurobiology Research Branch (GMNRB)
- Genetics Staff Contacts at NIDA
- Recent Findings from NIDA Grantees
- Statistical Training in Addiction Genetics (R25)
Other Genetics Resources:
- Collaborative Opportunities in Genetics Research
- Epigenetic Resources
- Gene Expression
- Genomes
- Human Genetics
- Knowledgebase for Addiction Related Genes (KARG)
- Mouse
- Nucleotide
- Phenotype-Genotype Integrator
- Twin Registries
Cell Biology and Neuroscience Resources:
- Cell Biology
- Model Organisms
- Mouse
- Neuroscience Information Framework
- Proteins
- Tissue and Cell Repositories
Mailing Address:
Jonathan D. Pollock, Ph.D.
Chair, NIDA Genetics Workgroup
6001 Executive Drive, RM 4274
Bethesda, MD 20892
Tel. 301-435-1309
Fax. 301-594-6043
Attention
Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at
Looking for Treatment?
Use the SAMHSA Treatment Locator or 1-800-662-HELP.
Helpline open during government shutdown
Featured Publication
2010 Strategic Plan
Outlines NIDA’s drug abuse and addiction research strategic priorities for the next 5 years, focusing on prevention, treatment, HIV/AIDS, and other cross-cutting issues.